Third Annual Translational Hypertension Symposium and Early-Stage Investigator Workshop

The Third Annual University of Utah Translational Hypertension Symposium will be held on Thursday, October 10^th from 8:00am to 6:30pm, in the upstairs ballroom of the Cleone Peterson Eccles Alumni House on the University of Utah campus in Salt Lake City, Utah (155 S. Central Campus Drive, Salt Lake City, UT 84112).

This event is free and open to the public. For full details please visit our website. To register, please RSVP.

High blood pressure affects more than a billion people worldwide and remains a leading modifiable cause of heart disease and health disparities. New in-and out-of-office blood pressure measurement devices and strategies are being tested to more efficiently and accurately screen and diagnose hypertension for people from all communities and backgrounds. Antihypertensive medications are being combined in news ways to increase effectiveness, limit side effects, while maximizing patient acceptance and adherence. Together, the ultimate goal is more accurate diagnosis and more effective and durable blood pressure control and cardiovascular disease risk reduction for all communities.

The 2019 symposium addresses these topics and more. Featured speakers include:

• Keynote speaker Gbenga Ogedegbe, MD, MPH, New York University: FAITH trial results and targeted intervention to improve blood pressure management and outcomes in underrepresented groups.
• Mark D. Huffman, MD, MPH, Northwestern University: The role of low-dose combination therapy.
• Jackson T. Wright, MD, PhD, Case Western Reserve University: Hypertension management in underrepresented groups.
• Natalie Bello, MD, MPH, Columbia University: Out-of-office blood pressure measurement in pregnancy.
• Yuichiro Yano, MD, PhD, Duke University: Current challenges in out-of-office blood pressure measurement.
• Dave L. Dixon, PharmD, FACC, Virginia Commonwealth University: Team-based care approaches to controlling hypertension.
• Andrew Moran, MD, MPH, Columbia University: The global hypertension control program, Resolve to Save Lives.

The Early-Stage Investigator (ESI) Workshop takes place the day after the symposium and is a full day, intensive mentoring session where ESIs learn how to access and design hypertension-related analyses using the Jackson Heart Study (JHS) and The Coronary Artery Risk Development in Young Adults (CARDIA) study data and write clear manuscript proposals. This year, there will be a focus on using the ambulatory blood pressure monitoring data in these two chohorts. The objective is to teach ESIs about the manuscript proposal process, data access, and BP-related research methods for the JHS and CARDIA study. Senior JHS and CARDIA investigators will provide one-on-one feedback, and facilitate group discussions to enable ESIs to use and access the JHS and CARDIA data. Applications for the ESI Workshop are due Thursday, August 1^st and awardees will be notified no later than August 16^th, 2019.

To apply for the ESI Workshop, please visit this webpage. 

This year’s symposium is sponsored, in part, by the National Heart Lung and Blood Institute.